Our Mission: Building a Clinical Trials Management System for the BSD
Following a competitive proposal process, the Center for Research Informatics has been selected to lead the development of an enterprise clinical trials management system (CTMS) to unify clinical research efforts across the University of Chicago’s Biological Sciences Division (BSD). The ARTEMIS project was officially launched in October 2016. Since then, we’ve assembled our team, gathered requirements, and designed the system architecture. The source code development phase kicked off on August 9, 2017.
The CRI is working closely with Bad Rabbit Consulting to build the new system and integrate it into the existing BSD information system environment. As the development phase is completed, the CRI team will lead a new branch of operations dedicated to evolving the system further within the clinical trials ecosystem and supporting BSD clinical informatics as a whole.
Why build a new system?
With multiple CTMS products available in today’s market, the BSD makes an ambitious choice by opting for a custom-built, in-house solution. Bringing our extensive experience in building exceptional research applications to this project, the CRI sees this as an opportunity to raise the bar for the industry. Our team will build a solution that is more cost-effective, responsive, and flexible than anything currently available.
The CRI team brings a deep understanding of the University’s needs, stakeholders, and existing systems that could never be matched by an outside vendor, as well as domain expertise across all aspects of the clinical trials management process. We understand and value the needs of people involved in all phases of this process, from patients and clinicians to biomedical researchers to institutional business leaders. With input from subject matter experts across the University and a partnership with Bad Rabbit Consulting, known for their track record of building successful research technology products, the CRI is poised to build a solution that will change the face of clinical trials management.
Join us as we embark on this exciting project. Updates will be posted here as the build-out continues.